SOTERA HEALTH CO (SHC) Stock Analyst Ratings
USA - NASDAQ:SHC - US83601L1026 - Common Stock
16.86 USD
-0.04 (-0.24%)
16.53 USD
-0.33 (-1.96%)
ChartMill assigns a Buy % Consensus number of 80% to SHC. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 16.73. This target is -0.78% below the current price.
SHC was analyzed by 11 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about SHC.
In the previous month the buy percentage consensus was at a similar level.
SHC was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-02 | Barclays | Maintains | Overweight -> Overweight |
| 2025-06-24 | Barclays | Maintains | Overweight -> Overweight |
| 2025-05-05 | Goldman Sachs | Upgrade | Neutral -> Buy |
| 2025-04-23 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-04-10 | Barclays | Maintains | Overweight -> Overweight |
| 2025-02-28 | Barclays | Maintains | Overweight -> Overweight |
| 2025-02-18 | Barclays | Maintains | Overweight -> Overweight |
| 2024-11-21 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-11-06 | Citigroup | Maintains | Buy -> Buy |
| 2024-08-06 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-08-06 | Barclays | Maintains | Overweight -> Overweight |
| 2024-05-21 | Piper Sandler | Initiate | Neutral |
| 2024-04-10 | Barclays | Maintains | Overweight -> Overweight |
| 2024-04-03 | Citigroup | Upgrade | Neutral -> Buy |
| 2024-03-25 | Jefferies | Upgrade | Hold -> Buy |
| 2024-03-11 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-03-04 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-02-28 | Barclays | Maintains | Overweight -> Overweight |
| 2024-02-06 | Keybanc | Initiate | Sector Weight |
| 2024-01-25 | Barclays | Maintains | Overweight -> Overweight |
| 2023-11-02 | RBC Capital | Maintains | Outperform -> Outperform |
| 2023-11-02 | Barclays | Maintains | Overweight -> Overweight |
| 2023-08-04 | Keybanc | Maintains | Overweight -> Overweight |
| 2023-08-04 | RBC Capital | Maintains | Outperform -> Outperform |
| 2023-06-26 | Keybanc | Upgrade | Sector Weight -> Overweight |
| 2023-06-22 | Keybanc | Maintains | Sector Weight |
| 2023-05-04 | RBC Capital | Maintains | Outperform |
| 2023-05-04 | Barclays | Maintains | Overweight |
| 2023-04-04 | Barclays | Maintains | Overweight |
| 2023-03-01 | RBC Capital | Maintains | Outperform |
SOTERA HEALTH CO / SHC FAQ
What is the price target for SHC stock?
11 analysts have analysed SHC and the average price target is 16.73 USD. This implies a price decrease of -0.78% is expected in the next year compared to the current price of 16.86.
Can you provide the consensus rating for SOTERA HEALTH CO stock?
The consensus rating for SOTERA HEALTH CO (SHC) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.